| Acute rheumatic fever and rheumatic heart disease JR Carapetis, A Beaton, MW Cunningham, L Guilherme, G Karthikeyan, ... Nature reviews Disease primers 2 (1), 1-24, 2016 | 569 | 2016 |
| Position statement of the World Heart Federation on the prevention and control of rheumatic heart disease B Remenyi, J Carapetis, R Wyber, K Taubert, BM Mayosi Nature Reviews Cardiology 10 (5), 284-292, 2013 | 320 | 2013 |
| Big data in global health: improving health in low-and middle-income countries R Wyber, S Vaillancourt, W Perry, P Mannava, T Folaranmi, LA Celi Bulletin of the World Health Organization 93, 203-208, 2015 | 235 | 2015 |
| Rheumatic Heart Disease Worldwide: JACC Scientific Expert Panel DA Watkins, AZ Beaton, JR Carapetis, G Karthikeyan, BM Mayosi, ... Journal of the American College of Cardiology 72 (12), 1397-1416, 2018 | 204 | 2018 |
| The 2020 Australian guideline for prevention, diagnosis and management of acute rheumatic fever and rheumatic heart disease AP Ralph, S Noonan, V Wade, BJ Currie Medical Journal of Australia 214 (5), 220-227, 2021 | 201* | 2021 |
| Global disease burden of group A Streptococcus AS Sanyahumbi, S Colquhoun, R Wyber, JR Carapetis Streptococcus pyogenes: basic biology to clinical manifestations [Internet], 2016 | 161* | 2016 |
| Contemporary incidence and prevalence of rheumatic fever and rheumatic heart disease in Australia using linked data: the case for policy change JM Katzenellenbogen, D Bond‐Smith, RJ Seth, K Dempsey, J Cannon, ... Journal of the American Heart Association 9 (19), e016851, 2020 | 87 | 2020 |
| Benzathine penicillin G for the management of RHD: concerns about quality and access, and opportunities for intervention and improvement R Wyber, K Taubert, S Marko, EL Kaplan Global heart 8 (3), 227-234, 2013 | 71 | 2013 |
| Rheumatic heart disease: infectious disease origin, chronic care approach JM Katzenellenbogen, AP Ralph, R Wyber, JR Carapetis BMC health services research 17, 1-16, 2017 | 62 | 2017 |
| The WHF roadmap for reducing CV morbidity and mortality through prevention and control of RHD B Palafox, AO Mocumbi, RK Kumar, SKM Ali, E Kennedy, A Haileamlak, ... Global heart 12 (1), 47-62, 2017 | 55 | 2017 |
| Ending rheumatic heart disease in Australia: the evidence for a new approach R Wyber, K Noonan, C Halkon, S Enkel, J Cannon, E Haynes, AG Mitchell, ... Medical Journal of Australia 213, S3-S31, 2020 | 43 | 2020 |
| Tools for implementing RHD control programmes (TIPS) handbook R Wyber, A Grainger Gasser, D Thompson, D Kennedy, T Johnson, ... Perth, Australia: World Heart Federation and RhEACH, 2014 | 43 | 2014 |
| The case for global investment in rheumatic heart-disease control R Wyber, L Zühlke, J Carapetis Bulletin of the World Health Organization 92, 768-770, 2014 | 39 | 2014 |
| Voices behind the statistics: a systematic literature review of the lived experience of rheumatic heart disease E Haynes, A Mitchell, S Enkel, R Wyber, D Bessarab International Journal of Environmental Research and Public Health 17 (4), 1347, 2020 | 37 | 2020 |
| The American Heart Association’s call to action for reducing the global burden of rheumatic heart disease: a policy statement from the American Heart Association A Beaton, FB Kamalembo, J Dale, JH Kado, G Karthikeyan, DS Kazi, ... Circulation 142 (20), e358-e368, 2020 | 32 | 2020 |
| For better or worse: role models for New Zealand house officers R Wyber, T Egan The New Zealand Medical Journal (Online) 120 (1253), 2007 | 31 | 2007 |
| Prevention of rheumatic fever and heart disease: Nepalese experience PR Regmi, R Wyber Global heart 8 (3), 247-252, 2013 | 30 | 2013 |
| The RHD Endgame Strategy; the blueprint to eliminate rheumatic heart disease in Australia by 2031 R Wyber, K Noonan, C Halkon, S Enkel, J Carapetis European Journal of Public Health 30 (Supplement_5), ckaa165. 059, 2020 | 28 | 2020 |
| The End Rheumatic Heart Disease in Australia Study of Epidemiology (ERASE) Project: data sources, case ascertainment and cohort profile JM Katzenellenbogen, D Bond-Smith, RJ Seth, K Dempsey, J Cannon, ... Clinical Epidemiology, 997-1010, 2019 | 27 | 2019 |
| Preliminary consultation on preferred product characteristics of benzathine penicillin G for secondary prophylaxis of rheumatic fever R Wyber, BJ Boyd, S Colquhoun, BJ Currie, M Engel, J Kado, ... Drug Delivery and Translational Research 6, 572-578, 2016 | 27 | 2016 |
